[O-11] Parkinsonism and Related disorders (Drug discovery)

[O-11-2] Progression of clinical milestones by clinical types in Progressive supranuclear palsy

^○Ikuko Aiba¹, Takeshi Ikeuchi², Hiroshi Takigawa³, Takahiko Tokuda⁴, Takayoshi Shimohata⁵, Mitsuya Morita⁶, Shigeo Murayama⁷, Osamu Onodera⁸, Kazuko Hasegawa⁹, Hisanori Kowa¹⁰, Ritsuko Hanajima³, Nakashima Kenji¹⁰, JALPAC consortium² (1.Depatrment of Neurology, National Hospital Organization, Higashinagoya National Hospital, 2.Molecular Genetics, Brain Research Institute, Niigata University, 3.Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, 4.Department of Molecular Pathobiology of Brain Diseases, Kyoto Prefectural University of Medicine, 5.Depatrment of Neurology and Geriatrics, Gifu University Graduate School of Medicine, 6.Division of Neurology, Department of Internal Medicine, Jichi Medical University, 7.Department of Neurology and Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 8.Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 9.Department of Neurology, National Hospital Organization, Sagamihara National Hospital, 10.Department of Neurology, National Hospital Organization, Matsue Medical Center)